Article
Use of the steroid derivative RPR 106541 in combination with site-directed mutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis.
The Journal of pharmacology and experimental therapeutics - 1 Aug 1999
Stevens J C, Domanski T L, Harlow G R, White R B, Orton E, Halpert J R
Abstract excerpt
RPR 106541 (20R-16alpha,17alpha-[butylidenebis(oxy)]-6al pha, 9alpha-difluoro-11beta-hydroxy-17beta-(methylthio)androst a-4-en-3-one) is an airway-selective steroid developed for the treatment of asthma. Two metabolites produced by human liver microsomes were identified as R- and S-sulfoxide diastereomers based on liquid chromatography/mass spectrometry analysis, proton nuclear magnetic resonance, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
